dipyridamole has been researched along with 8-bromocyclic gmp in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fyhrquist, F; Saijonmaa, O | 1 |
| Barba, G; Donald, A; MacAllister, RJ; Mullen, MJ | 1 |
| Mullan, M; Paris, D; Town, T | 1 |
| Humphrey, J; Mullan, M; Paris, D; Parker, T; Town, T | 1 |
| Abraham, RZ; Kobzik, L; Moody, MR; Reid, MB; Stamler, JS | 1 |
| Huang, Y; Kong, SK; Kwan, HY; Yao, X | 1 |
6 other study(ies) available for dipyridamole and 8-bromocyclic gmp
| Article | Year |
|---|---|
Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; Peptidyl-Dipeptidase A; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Purinones; Stimulation, Chemical; Thionucleotides; Umbilical Veins; Vasodilator Agents | 1998 |
Determinants of the response of human blood vessels to nitric oxide donors in vivo.
Topics: Adult; Bradykinin; Cyclic GMP; Dipyridamole; Forearm; Hand; Humans; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Radial Artery; Vascular Resistance; Vasodilation; Veins | 1999 |
Novel strategies for opposing murine microglial activation.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cells, Cultured; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dipyridamole; Enzyme Inhibitors; Flavonoids; Guanylate Cyclase; Imidazoles; Indazoles; Isoenzymes; Lipopolysaccharides; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Microglia; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylcholine; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha | 2000 |
beta-Amyloid vasoactivity and proinflammation in microglia can be blocked by cGMP-elevating agents.
Topics: Amyloid beta-Peptides; Animals; Aorta; Cyclic GMP; Dipyridamole; Endothelin-1; In Vitro Techniques; Inflammation; Leukotriene B4; Microglia; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Rats; Vasoconstriction | 2000 |
Cyclic GMP is a second messenger by which nitric oxide inhibits diaphragm contraction.
Topics: Aminoquinolines; Animals; Cyclic GMP; Diaphragm; Dipyridamole; Enzyme Inhibitors; Guanylate Cyclase; Male; Muscle Contraction; Nitric Oxide; Nitroarginine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Second Messenger Systems | 1998 |
cGMP abolishes agonist-induced [Ca(2+)](i) oscillations in human bladder epithelial cells.
Topics: Acetylcholine; Alkaloids; Bradykinin; Calcium Signaling; Calcium-Transporting ATPases; Carbazoles; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dipyridamole; Drug Antagonism; Enzyme Inhibitors; Epithelial Cells; Humans; Indoles; Kinetics; Macrocyclic Compounds; Oxazoles; Phosphodiesterase Inhibitors; Urinary Bladder | 2001 |